Subscribe to our newsletter

Alopecia Areata Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.


Contact the Alopecia Areata Registry Team

The Alopecia Areata (AA) Registry is a prospective, observational cohort study for subjects with AA under the care of a dermatology provider. The registry is designed to study the natural history of AA, the real-world effectiveness and safety of medications used in the treatment of AA, and drug utilization treatment patterns.
Structured clinical data are collected approximately every 6 months at regular office visits from patients and providers at the time of routine clinical encounters.

A minimum of 5,000 patients and 100 clinical sites in the U.S. and Canada will be recruited to participate in the CorEvitas AA Registry.

Contact the Dermatology Registry Team: